Neuroscience and Behavioral Physiology

, Volume 37, Issue 6, pp 601–606 | Cite as

Relationship between dopamine system genes and extraversion and novelty seeking

  • V. E. Golimbet
  • M. V. Alfimova
  • I. K. Gritsenko
  • R. P. Ebstein


Dopamine transmission is known to play an important role in the reinforcement system of the brain. Studies have identified dopamine system genes whose polymorphic variants have been linked with the intensity of psychological traits reflecting the tendency to form behaviors characterized by impulsivity and the need for additional stimulation. The aim of the present work was to seek associations between polymorphisms in the catechol-O-methyltransferase (COMT) and D4 dopamine receptor (DRD4) genes and personality traits in the Russian population. Studies of 130 subjects showed that carriers of the Met/Met genotype of the COMT gene had a greater intensity of the novelty-seeking trait than carriers of the Val/Val and Val/Met genotypes, though this association was seen only in women. In addition, the presence of the C allele of the DRD4 gene in carriers of the Met/Met genotype showed high levels of extraversion and hypomania. These results are consistent with current theoretical concepts of the regulation of dopamine transmission in the brain.

Key words

dopamine reinforcement system gene polymorphism novelty-seeking extraversion dopamine receptor catechol-O-methyltransferase 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    V. E. Golimbet, I. K. Gritsenko, M. V. Alfimova, and R. P. Ebstein, “Polymorphic markers of the promoter region of the D4 dopamine receptor gene and temperament in mentally healthy humans from the Russian population,” Genetika, 41, No. 7, 966–972 (2005).PubMedGoogle Scholar
  2. 2.
    R. M. Bilder, J. Volavka, H. M. Lachman, and A. A. Grace, “The catechol-O-methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes,” Neuropsychopharmacology, 29, No. 11, 1943–1961 (2004).PubMedCrossRefGoogle Scholar
  3. 3.
    E. B. Bookman, R. E. Taylor, L. Adams-Campbell, and R. A. Kittles, “DRD4 promoter SNPs and gender effects on Extraversion in African Americans,” Mol. Psychiatry, 7, No. 7, 786–789 (2002).PubMedCrossRefGoogle Scholar
  4. 4.
    J. Chen, B. K. Lipska, N. Halim, Q. D. Ma, M. Matsumoto, S. Melhem, B. S. Kolachana, T. M. Hyde, M. M. Herman, J. Apud, M. F. Egan, J. E. Kleinman, and D. R. Weinberger, “Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain,” Amer. J. Hum. Genet., 75, No. 5, 807–821 (2004).PubMedCrossRefGoogle Scholar
  5. 5.
    R. P. Ebstein, O. Novick, R. Umansky, B. Priel, Y. Osher, D. Blaine, E. R. Bennett, L. Nemanov, M. Katz, and R. H. Belmaker, “Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of Novelty Seeking,” Nat. Genet., 12, No. 1, 78–80 (1996).PubMedCrossRefGoogle Scholar
  6. 6.
    J. Ekelund, J. Suhonen, M. R. Jarvelin, L. Peltonen, and D. Lichtermann, “No association of the −521 C/T polymorphism in the promoter of DRD4 with novelty seeking,” Mol. Psychiatry, 6, No. 6, 618–719 (2001).PubMedCrossRefGoogle Scholar
  7. 7.
    J. A. Gogos, M. Morgan, V. Luine, M. Santha, S. Ogawa, D. Pfaff, and M. Karayiorgou, “Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior,” Proc. Natl. Acad. Sci. USA, 95, No. 17, 9991–9996 (1998).PubMedCrossRefGoogle Scholar
  8. 8.
    H. Herken and M. E. Erdal, “Catechol-O-methyltransferase gene polymorphism in schizophrenia: evidence for association between symptomatology and prognosis,” Psychiatr. Genet., 11, No. 2, 105–109 (2001).PubMedCrossRefGoogle Scholar
  9. 9.
    J. Kauhanen, T. Hallikainen, T. P. Tuomainen, M. Koulu, M. K. Karvonen, and J. T. Aalonen, “Association between the functional polymorphism of catechol-O-methyltransferase gene and alcohol consumption among social drinkers,” Alcoholism: Clin. Exptl. Res., 24, 135–139 (2000).CrossRefGoogle Scholar
  10. 10.
    H. J. Lachman, K. A. Nolan, P. Mohr, T. Saito, and J. Volavka, “Association between catechol O-methyltransferase genotype and violence in schizophrenia and schizoaffective disorder,” Amer. J. Psychiatry, 155, 835–837 (1998).Google Scholar
  11. 11.
    H. J. Lee, H. S. Lee, Y. K. Kim, S. H. Kim, L. Kim, M. S. Lee, S. H. Joe, I. K. Jung, K. Y. Suh, and S. Kim, “Allelic variants interaction of dopamine receptor D4 polymorphism correlate with personality traits in young Korean female population,” Amer. J. Med. Genet., 118B, No. 1, 76–80 (2003).CrossRefGoogle Scholar
  12. 12.
    A. K. Malhotra, L. J. Kestler, C. Mazzanati, J. A. Bates, T. Goldberg, and D. Goldman, “A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition,” Amer. J. Psychiatry, 159, No. 4, 652–654 (2002).CrossRefGoogle Scholar
  13. 13.
    M. Matsumoto, K. Hidaka, S. Tada, Y. Tasaki, and T. Yamaguchi, “Low levels of mRNA for dopamine D4 receptor in human cerebral cortex and striatum,” J. Neurochem., 66, No. 3, 915–919 (1996).PubMedCrossRefGoogle Scholar
  14. 14.
    M. Matsumoto, C. S. Weickert, S. Beltaifa, B. Kolachana, J. Chen, T. M. Hyde, M. M. Herman, D. R. Weinberger, and J. E. Kleinman, “Catechol O-methyltransferase (COMT) mRNA expression in the dorsolateral prefrontal cortex of patients with schizophrenia,” Neuropsychopharmacology, 28, No. 8, 1521–1530 (2003).PubMedCrossRefGoogle Scholar
  15. 15.
    A. Meyer-Lindenberg, P. D. Kohn, B. Kolachana, S. Kippenham, A. McInerney-Leo, R. Nussbaum, D. R. Weinberger, and K. F. Berman, “Midbrain dopamine and prefrontal function in humans: interaction and modulation by COMT genotype,” Nat. Neurosci., 8, No. 5, 594–596 (2005).PubMedCrossRefGoogle Scholar
  16. 16.
    K. A. Nolan, J. Volavka, P. Czobor, A. Cseh, H. Lachman, T. Saito, J. Tiihonen, A. Putkonen, T. Hallikainen, I. Kotilainen, P. Rasanen, M. Isohanni, M. R. Jarvelin, and M. K. Karvonen, “Suicidal behavior in patients with schizophrenia is related to COMT polymorphism,” Psychiatr. Genet., 10, 117–124 (2000).PubMedCrossRefGoogle Scholar
  17. 17.
    Y. Okuyama, H. Ishiguro, M. Nankai, H. Shibuya, A. Watanabe, and T. Arinami, “Identification of a polymorphism in the promoter region of DRD4 associated with the human novelty seeking personality trait,” Mol. Psychiatry, 5, 64–69 (2000).PubMedCrossRefGoogle Scholar
  18. 18.
    M. A. Palmatier, A. M. Kang, and K. K. Kidd, “Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles,” Biol. Psychiatry, 46, No. 4, 557–567 (1999).PubMedCrossRefGoogle Scholar
  19. 19.
    M. Reuter and J. Hennig, “Association of the functional catechol-O-methyltransferase VAL158MET polymorphism with the personality trait of extraversion,” Neuroreport, 16, No. 10, 1135–1138 (2005).PubMedCrossRefGoogle Scholar
  20. 20.
    Z. Ronai, A. Szekely, Z. Nemoda, K. Lakatos, J. Gervai, M. Staub, and M. Sasvari-Szekely, “Association between Novelty Seeking and the −521 C/T polymorphism in the promoter region of the DRD4 gene,” Mol. Psychiatry, 6, No. 1, 35–38 (2001).PubMedCrossRefGoogle Scholar
  21. 21.
    A. Rotondo, C. Mazzanti, L. Dell-Osso, P. Rucci, P. Sullivan, S. Bouanani, C. Gonnelli, D. Goldman, and G. B. Cassano, “Catechol-O-methyltransferase, serotonin transporter, and tryptophan hydroxylase gene polymorphisms in bipolar disorder patients with and without comorbid panic disorder,” Amer. J. Psychiatry, 159, 23–29 (2002).CrossRefGoogle Scholar
  22. 22.
    M. Rubinstein, T. J. Phillips, J. R. Bunzow, T. L. Falzone, G. Dziewczapolski, G. Zhang, Y. Fang, J. L. Larson, J. A. McDougall, J. A. Chester, C. Saez, T. A. Pugsley, O. Gershanik, M. J. Low, and D. K. Grundy, “Mice lacking dopamine D4 receptors are supersensitive to ethanol, cocaine, and methamphetamine,” Cell, 90, 991–1001 (1997).PubMedCrossRefGoogle Scholar
  23. 23.
    D. Rujescu, I. Giegling, A. Gietl, A. M. Hartmann, and H. J. Moller, “A functional single nucleotide polymorphism (V158M) in the COMT gene is associated with aggressive personality traits,” Biol. Psychiatry, 54, 34–39 (2003).PubMedCrossRefGoogle Scholar
  24. 24.
    I. S. Sanya and H. H. Van Tol, “Review of the role of dopamine D4 receptors in schizophrenia and antipsychotic action,” J. Psychiatr. Res., 31, No. 2, 219–232 (1997).CrossRefGoogle Scholar
  25. 25.
    J. A. Schinka, E. A. Letsch, and F. C. Crawford, “DRD4 and novelty seeking: results of meta-analyses,” Amer. J. Med. Genet., 114, No. 6, 643–648 (2002).CrossRefGoogle Scholar
  26. 26.
    S. Shifman, M. Bronstein, M. Sternfeld, A. Pisante-Shalom, E. Lev-Lehman, A. Weizman, I. Reznik, B. Spivak, N. Grisaru, L. Karp, R. Schiffer, M. Kotler, R. D. Strous, M. Swartz-Vanetik, H.Y. Knobler, E. Shinar, J. S. Beckmann, B. Yakir, N. Risch, N. B. Zak, and A. Darvasi, “A highly significant association between a COMT haplotype and schizophrenia,” Amer. J. Hum. Genet., 71, No. 6, 1296–1302 (2002).PubMedCrossRefGoogle Scholar
  27. 27.
    R. D. Strous, N. Bark, S. S. Parsia, J. Volavka, and H. M. Lachman, “Analysis of a functional catechol-O-methyl-transferase gene polymorphism in schizophrenia: evidence for association with aggressive and antisocial behavior,” Psychiatry Res., 69, 71–77 (1997).PubMedCrossRefGoogle Scholar
  28. 28.
    S. J. Tsai, C. J. Hong, Y. W. Yu, and T. J. Chen, “Association study of catechol-O-methyltransferase gene and dopamine D4 receptor gene polymorphisms and personality traits in healthy young Chinese females,” Neuropsychobiology, 50, No. 2, 153–156 (2004).PubMedCrossRefGoogle Scholar
  29. 29.
    E. M. Tunbridge, D. M. Bannerman, T. Sharp, and P. J. Harrison, “Catechol-O-methyltransferase inhibition improves set-shifting performance and elevates stimulated dopamine release in the rat prefrontal cortex,” J. Neurosci., 24, No. 23, 5331–5335 (2004).PubMedCrossRefGoogle Scholar
  30. 30.
    D. R. Weinberger, M. F. Egan, A. Bertolino, J. H. Callicott, V. S. Mattay, B. K. Lipska, K. F. Berman, and T. E. Goldberg, “Prefrontal neurons and the genetics of schizophrenia,” Biol. Psychiatry, 50, No. 11, 825–844 (2001).PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2007

Authors and Affiliations

  • V. E. Golimbet
    • 1
  • M. V. Alfimova
    • 1
  • I. K. Gritsenko
    • 2
  • R. P. Ebstein
    • 2
  1. 1.Scientific Center for Mental HealthRussian Academy of Medical SciencesMoscow
  2. 2.Department of Psychology, Scheinfeld Center of Human GeneticsHebrew UniversityIsrael

Personalised recommendations